| abstract |
Human and other host of Flaviviridae virus, including HCV, comprising administering an effective amount of spiro [2.4] heptane or a pharmaceutically acceptable salt or prodrug thereof, as described herein, in a pharmaceutically acceptable carrier, Compounds, methods and compositions for treating infection or exposure to an animal are provided. The spiro [2.4] heptane compound possesses antiviral activity or is metabolized to a compound exhibiting such activity. |